References
Blumberg PM, Acs G, Acs P, Areces LB, Kazanietz MG, Lewin NE et al. Protein kinase C in cell signaling: Strategies for the development of selective inhibitors. Agents and Actions 1995; 47: 87–97.
Proteau PJ, Gerwick WH, Garcia-Pichel F, Castenholtz R. The structure of scytonemin, an ultraviolet sunscreen pigment from the sheaths of cyanobacteria. Experentia 1993; 49: 825–9.
Roshak AK, Capper EA, Imburgia C, Fomwall J, Scott G, Marshall LA. The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase. Cell Signal 2000; 12:405–11.
Huang KP, Nakabayashi H, Huang FL. Isozymic forms of rat brain Ca2+-activated and phospholipid-dependent protein kinase. Proc Natl Acad Sci 1986; 83: 8535–9.
Roshak AK, Anderson KM, Holmes SD, Jonak Z, Bolognese B, Terrett J et al. Anti-RP105 sera induces lymphocyte proliferation. J Leukoc Biol 1999; 65: 43–9.
Jacobson PB, Jacobs RS. Fuscoside: an anti-inflammatory marine natural product which selectively inhibits 5-lipoxygenase. Part I: Physiological and biochemical studies in murine inflammatory models. J Pharmacol Exp Ther 1992; 262: 866–73.
Kumagai A, Dunphy WG. The cdc25 protein controls the tyrosine dephosphorylation of the cdc2 protein in a cell free system. Cell 1991; 64: 903–14.
Kuchera S, Barth H, Jacobson P, Metz A, Schrier D. Anti-inflammatory properties of the protein kinase C inhibitor, 3-[l-[3-(di-methylamino)propyl]-1 H-indol-3-yl]-4-(l H-indol-3-yl)-l H-pyrrole-2,5-dione monohydrochloride (GF109203X) in the PMA-mouse ear edema model. Agents and Actions 1993; 39: 169–75.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stevenson, C.S., Capper, E.A., Roshak, A.K. et al. Scytonemin-a marine natural product inhibitor of kinases key in hyperproliferative inflammatory diseases. Inflamm Res 51, 112–114 (2002). https://doi.org/10.1007/BF02684014
Issue Date:
DOI: https://doi.org/10.1007/BF02684014